Quantitative genetic study of amphiregulin and fractalkine circulating levels - potential markers of arthropathies

Osteoarthritis and Cartilage

Volumn 19, Issue 6, 2011, Pages 737-742

  Leonov, A ^a   Trofimov, S ^a   Ermakov, S ^a   Livshits, G ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

AREG; Common familial environment; FRACT; Heritability; Osteoarthritis; Plasma

Indexed keywords

AMPHIREGULIN; BIOLOGICAL MARKER; FRACTALKINE;

ARTHROPATHY; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FEMALE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEREDITY; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS;

ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CHEMOKINE CX3CL1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLYCOPROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; JOINT DISEASES; MALE; OSTEOARTHRITIS; POLYMORPHISM, GENETIC;

EID: 79955971459     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2011.02.013     Document Type: Article

References (30)

1. Oda K., Matsuoka Y., Funahashi A., Kitano H. A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol 2005, 1. 2005.0010.
2. Barrientos S., Stojadinovic O., Golinko M.S., Brem H., Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen 2008, 16(5):585-601.
3. Willmarth N.E., Ethier S.P. Amphiregulin as a novel target for breast cancer therapy. J Mammary Gland Biol Neoplasia 2008, 13(2):171-179.
4. Rittié L., Varani J., Kang S., Voorhees J.J., Fisher G.J. Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin-binding EGF and amphiregulin in human skin in vivo. J Invest Dermatol 2006, 126(4):732-739.
5. Berasain C., Castillo J., Perugorría M.J., Prieto J., Avila M.A. Amphiregulin: a new growth factor in hepatocarcinogenesis. Cancer Lett 2007, 254(1):30-41.
6. Qin L., Tamasi J., Raggatt L., Li X., Feyen J.H., Lee D.C., et al. Amphiregulin is a novel growth factor involved in normal bone development and in the cellular response to parathyroid hormone stimulation. J Biol Chem 2005, 280(5):3974-3981.
7. Nilsson A., Kanje M. Amphiregulin acts as an autocrine survival factor for adult sensory neurons. Neuroreport 2005, 16(3):213-218.
8. Yamane S., Ishida S., Hanamoto Y., Kumagai K., Masuda R., Tanaka K., et al. Proinflammatory role of amphiregulin, an epidermal growth factor family member whose expression is augmented in rheumatoid arthritis patients. J Inflamm (Lond) 2008, 5:5.
9. Nakamura N., Shimaoka Y., Tougan T., Onda H., Okuzaki D., Zhao H. Isolation and expression profiling of genes upregulated in bone marrow-derived mononuclear cells of rheumatoid arthritis patients. DNA Res 2006, 13(4):169-183.
10. Ruth J.H., Volin M.V., Haines G.K., Woodruff D.C., Katschke K.J., Woods J.M., et al. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Arthritis Rheum 2001, 44(7):1568-1581.
11. D'Haese J.G., Demir I.E., Friess H., Ceyhan G.O. Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential. Expert Opin Ther Targets 2010, 14(2):207-219.
12. Whitel G.E., Tan T.C.C., John A.E., Whatling C., McPheat W.L., Greaves D.R. Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling. Cardiovasc Res 2010, 85(4):825-835.
13. Iwamoto T., Okamoto H., Toyama Y., Momohara S. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. FEBS J 2008, 275(18):4448-4455.
14. Dawson J., Miltz W., Mir A.K., Wiessner C. Targeting monocyte chemoattractant protein-1 signalling in disease. Expert Opin Ther Targets 2003, 7(1):35-48.
15. Pantsulaia I., Trofimov S., Kobyliansky E., Livshits G. Contribution of the familial and genetic factors on monocyte chemoattractant protein-1 variation. Cytokine 2005, 32(2):117-123.
16. Korostishevsky M., Cohen Z., Malkin I., Ermakov S., Yarenchuk O., Livshits G. Morphological and biochemical features of obesity are associated with mineralization genes' polymorphisms. Int J Obes (Lond) 2010, 34(8):1308-1318.
17. Livshits G., Karasik D., Kobyliansky E. Complex segregation analysis of the radiographic phalanges bone mineral density and their age-related changes. J Bone Miner Res 2002, 17(1):152-161.
18. Kalichman L., Malkin I., Livshits G., Pavlovsky O., Batsevich V., Kobyliansky E. Variation of skeletal biomarkers of biological aging in a Chuvashian population: a longitudinal study. Am J Hum Biol 2007, 19(1):74-81.
19. STATISTICA (Data Analysis Software System), Version 7.1 2005, StatSoft Inc. http://www.statsoft.com.
20. Malkin I., Ginsburg E. Program Package for Mendelian Analysis of Pedigree Data (MAN, Version 9) 2009, Department of Anatomy and Anthropology, Sackler Faculty of Medicine, Tel Aviv University; Technical Report.
21. Falconer D.S., Mackay T.F.C. Introduction to Quantitative Genetics 1996, Longman, London. 4th edn.
22. Hansen P.S., Brix T.H., Iachine I., Sørensen T.I., Kyvik K.O., Hegedüs L. Genetic and environmental interrelations between measurements of thyroid function in a healthy Danish twin population. Am J Physiol Endocrinol Metab 2007, 292(3):E765-E770.
23. Livshits G., Gerber L.M. Familial factors of blood pressure and adiposity covariation. Hypertension 2001, 37(3):928-935.
24. Klosowska K., Volin M.V., Huynh N., Chong K.K., Halloran M.M., Woods J.M. Fractalkine functions as a chemoattractant for osteoarthritis synovial fibroblasts and stimulates phosphorylation of mitogen-activated protein kinases and Akt. Clin Exp Immunol 2009, 156(2):312-319.
25. Borzi R.M., Mazzetti I., Marcu K.B., Facchini A. Chemokines in cartilage degradation. Clin Orthop Relat Res 2004, 427:S53-S61.
26. Lu H.T., Liang Y.C., Sheu M.T., Ho H.O., Lin Y.T., Hsieh M.S., et al. Disease-modifying effects of glucosamine HCl involving regulation of metalloproteinases and chemokines activated by interleukin-1beta in human primary synovial fibroblasts. J Cell Biochem 2008, 104(1):38-50.
27. Bondeson J., Lauder S., Wainwright S., Amos N., Evans A., Hughes C., et al. Adenoviral gene transfer of the endogenous inhibitor IkappaBalpha into human osteoarthritis synovial fibroblasts demonstrates that several matrix metalloproteinases and aggrecanases are nuclear factor-kappaB-dependent. J Rheumatol 2007, 34(3):523-533.
28. Livshits G. Quantitative genetics of circulating molecules associated with bone metabolism: a review. J Musculoskelet Neuronal Interact 2006, 6(1):47-61.
29. Williams F.M., Andrew T., Saxne T., Heinegard D., Spector T.D., MacGregor A.J. The heritable determinants of cartilage oligomeric matrix protein. Arthritis Rheum 2006, 54(7):2147-2151.
30. Wörns M.A., Victor A., Galle P.R., Höhler T. Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 levels-a study in twins. Genes Immun 2006, 7(7):600-605.